A Trial of CM-AT in Children With Autism- Open Label Extension Study

Status:
Completed

Trial end date:
2016-02-01

Target enrollment:

Participant gender:

The purpose of this study is to determine whether CM-AT is effective in treating the core symptoms of autism.

Phase 3

Curemark